Author

Marco Antonio Álvarez-González 1

1 Hospital del Mar,Barcelona,Spain

1L NER1006 REPRODUCIBLY EXCEEDS THE EUROPEAN SOCIETY OF GASTROINTESTINAL ENDOSCOPY MINIMUM TARGET RATE OF 90% ADEQUATE-LEVEL CLEANSING SUCCESS IN ALL COLON SEGMENTS WHEN ASSESSED BY TREATMENT-BLINDED CENTRAL READERS USING TWO VALIDATED COLON CLEANSING SCALES

Jonathan Manning, Marco Antonio Álvarez-González, Bharat Amlani, Cesare Hassan

COLON CLEANSING EFFICACY AND SAFETY OF 1L NER1006 IN PATIENTS WITH MILD TO MODERATE RENAL IMPAIRMENT: POST HOC ANALYSIS OF RANDOMISED PHASE 3 CLINICAL TRIALS

Marco Antonio Álvarez-González

DIAGNOSTIC ACCURACY OF THE NICE CLASSIFICATION FOR PREDICTING DEEP SUBMUCOSAL INVASION IN COLON LESIONS ASSESSED IN VIVO. PRELIMINARY RESULT

Ignasi Puig, Maria Lopez Ceron, Maria Pellisé Urquiza, Alberto Herrero Tejada de Echanojauregui, Anna Arnau, Marta Fornells Sala, Luisa de Castro, Angel Ferrandez, Oscar Nogales Rincon, Jorge López Vicente, Antonio Z Gimeno Garcia, Pablo Vega, Marta Hernández Conde, Henar Nuñez, Daniel Rodríguez-Alcalde, Aurora Burgos, Lise

EFFICACY AND SAFETY OF THE NOVEL 1L PEG AND ASCORBATE BOWEL PREPARATION NER1006 VERSUS STANDARD 2L PEG WITH ASCORBATE IN OVERNIGHT OR MORNING SPLIT-DOSING ADMINISTRATION: RESULTS FROM THE PHASE 3 STUDY MORA

Raf Bisschops, Jonathan Manning, Lucy B Clayton, Richard Ng Kwet Shing, Marco Antonio Álvarez-González

ENDOSCOPIC PROCEDURE AND ENDOSCOPISTS CHARACTERISTICS ASSOCIATED WITH THE DETECTION OF COLORECTAL LESIONS

Carolina Mangas-Sanjuan, Agustín Seoane, Marco Antonio Álvarez-González, Alberto Lué, Adolfo Suárez González, Veronica Alvarez Garcia, Luis Bujanda, Maria Isabel Portillo Villares, Natalia Gonzalez, Lucía Cid-Gómez, Joaquín Cubiella, Elena Rodríguez-Camacho, Marta Ponce Romerto, Pilar Diez Redondo, Maite Herraiz, Maria Pelli

GREATER HIGH-QUALITY RIGHT COLON CLEANSING WITH 1L NER1006 VERSUS 2L POLYETHYLENE GLYCOL + ASCORBATE OR ORAL SULFATE SOLUTION IN ALL PATIENTS WITH RIGHT COLON SCORES BY CENTRAL READERS: A POST-HOC ANALYSIS OF TWO RANDOMIZED CONTROLLED PHASE 3 CLINICAL TRIALS

Marco Antonio Álvarez-González, Juha Halonen, Alessandro Repici

GREATER HIGH-QUALITY RIGHT COLON CLEANSING WITH 1L NER1006 VERSUS 2L POLYETHYLENE GLYCOL + ASCORBATE OR ORAL SULFATE SOLUTION IN ALL PATIENTS WITH RIGHT COLON SCORES BY CENTRAL READERS: A POST-HOC ANALYSIS OF TWO RANDOMIZED CONTROLLED PHASE 3 CLINICAL TRIALS

Marco Antonio Álvarez-González

In patients with an overall cleansing success the 1L polyethylene glycol NER1006 achieves more high-quality cleansed segments per patient than three standard bowel preparations

Raf Bisschops, Jonathan Manning, Juha Halonen, Marco Antonio Álvarez-González

NARROW BAND IMAGING VERSUS WHITE LIGHT ENDOSCOPY IN THE CHARACTERIZATION OF RESIDUAL NEOPLASIA AFTER ENDOSCOPIC PIECEMEAL MUCOSAL RESECTION, A RANDOMIZED CONTROLLED TRIAL

Fausto Riu Pons, Montserrat Andreu, Javier Gimeno, Marco Antonio Álvarez-González, Agustín Seoane, Josep Maria Dedeu, Luis Barranco, Xavier Bessa

RANDOMIZED TANDEM COLONOSCOPY OF NARROW BAND IMAGING (NBI) AND WHITE LIGHT ENDOSCOPY IN PATIENTS WITH SERRATED LESIONS

Fausto Riu Pons, Montserrat Andreu, Dolores Naranjo, Marco Antonio Álvarez-González, Agustín Seoane, Josep Maria Dedeu, Luis Barranco, Xavier Bessa

Item 1 - 10 / 13
1
2